General Information of the Protein
Protein ID
PT03414
Protein Name
Hematopoietic prostaglandin D synthase
Secondarily
Protein Name
GST class-sigma
Glutathione S-transferase
Glutathione-dependent PGD synthase
Glutathione-requiring prostaglandin D synthase
Prostaglandin-H2 D-isomerase
Gene Name
HPGDS
Secondarily
Gene Name
GSTS
PGDS
PTGDS2
Sequence
MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Transferase
Function
Bifunctional enzyme which catalyzes both the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation, and the conjugation of glutathione with a wide range of aryl halides and organic isothiocyanates. Also exhibits low glutathione-peroxidase activity towards cumene hydroperoxide.
    Show/Hide
Uniprot ID
Primary ID:
O60760

Secondarily ID:
Q6FHT9
    Show/Hide
Ensembl ID
ENSG00000163106
HGNC ID
HGNC:17890
Subcellular Location
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000606 , MEG-01
Compound ID Compound Name Compound Formula
CP0571258
6-(3-fluorophenyl)-N-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]pyridine-3-carboxamide
   Show/Hide
C19H19F4N3O
 1
1
EC50 = 35 nM
   TI
   LI
   LO
   TS
CP0450029
N-[[4-[5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-pyridin-2-ylpyrimidine-5-carboxamide
   Show/Hide
C22H20N6O3
 1
1
EC50 = 74 nM
   TI
   LI
   LO
   TS
CP0238279
2-phenyl-5-(1H-pyrazol-3-yl)-1,3-thiazole
   Show/Hide
C12H9N3S
 1
1
EC50 = 110 nM
   TI
   LI
   LO
   TS
CP0560828
6-(3-methoxyphenyl)-N-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]pyridine-3-carboxamide
   Show/Hide
C20H22F3N3O2
 1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
CP0486857
3-(dimethylamino)-N-[5-(1H-indol-4-yl)pyridin-3-yl]propanamide
   Show/Hide
C18H20N4O
 1
1
EC50 = 350 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0663326
N-cyclopentyl-3-(3-cyclopropyl-1H-pyrazol-4-yl)-5H-pyrrolo[3,4-b]pyridine-6(7H)-carboxamide
   Show/Hide
C19H23N5O
 2
1 IC50 < 10 nM
2 IC50 = 40 nM
CP0238279
2-phenyl-5-(1H-pyrazol-3-yl)-1,3-thiazole
   Show/Hide
C12H9N3S
 1
1 IC50 = 21 nM
CP0843339
3-(3-cyclopropyl-1H-pyrazol-4-yl)-N-ethyl-5H-pyrrolo[3,4-b]pyridine-6(7H)-carboxamide
   Show/Hide
C16H19N5O
 2
1 IC50 = 40 nM
2 IC50 = 501 nM
Clinical Information about the Protein
Target 1 ( Glutathione-dependent PGD synthase (HPGDS) )
Target Type Successful Target
Disease 1 Target-related Disease  1
1 Flatworm infection [ICD-11: 1F70-1F86]
Approved Drug(s) 1 Approved Drug  1
1 Praziquantel Approved
Flatworm infection